Evidence map›Paper›PMID 37249796›Full record

ArticleEndocrine pathology2023

Gastric Amphicrine Carcinoma Showing Neuroendocrine and Pancreatic Acinar Cell Differentiation. Lesson from a Challenging Case Opening New Perspectives in the Diagnostic Work-Up of Gastric Neuroendocrine Neoplasms.

Amedeo Sciarra, Silvia Uccella, Philippe Hiroz, Ian Fournier, Vincent Soubeyran, Giovanna Finzi, Stefano La Rosa

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Endocrine pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Amedeo SciarraHistopathology, Central Institute, Valais Hospital, Avenue du Grand-Champsec 86, CH-1951, Sion, Switzerland. amedeo.sciarra@hopitalvs.ch.ORCID http://orcid.org/0000-0002-7550-0312
Silvia UccellaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanule, Milan, Italy.ORCID http://orcid.org/0000-0002-5714-7295
Philippe HirozGastroenterology, Valais Hospital, Sion, Switzerland.
Ian FournierGeneral Surgery, Valais Hospital, Sion, Switzerland.ORCID http://orcid.org/0000-0001-8625-8587
Vincent SoubeyranNuclear Medicine, Valais Hospital, Sion, Switzerland.
Giovanna FinziUnit of Pathology, Department of Oncology, ASST Sette Laghi, Varese, Italy.ORCID http://orcid.org/0000-0003-0253-8835
Stefano La RosaUnit of Pathology, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy.ORCID http://orcid.org/0000-0003-1941-2403
Hôpital du Valais · CHUniversity of Insubria · ITAziende Socio Sanitarie Territoriale dei Sette LaghiHumanitas University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amphicrine carcinomas are epithelial neoplasms composed of cells with co-existing exocrine-neuroendocrine phenotype and are challenging lesions from both diagnostic and therapeutic perspectives.Here, we report the case of a 63-year-old male patient with a gastric nodule that was endoscopically biopsied, revealing histological features of a type 3 well-differentiated gastric neuroendocrine tumor (NET). At imaging, the lesion was single and limited to the stomach, but did not present

Indexed as

CarcinomaCarcinoma, NeuroendocrineNeuroendocrine TumorsPancreatic NeoplasmsStomach NeoplasmsAcinar CellsCell DifferentiationHumansIntestinal NeoplasmsMaleMiddle AgedAcinar cell carcinomaAmphicrine carcinomaMiNENMixed neuroendocrine-non-neuroendocrine neoplasmStomach

Identifiers

PMID37249796
OpenAlexW4378745175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.